“…Meanwhile, other risks of topical steroids have become known, such as elevation of intraocular pressure, activation of ocular infection, worsening of viral infection and the development of cataract itself [6, 7, 8, 9, 10]. A better understanding of ocular and postsurgical inflammation, especially the breakdown of cell membrane phospholipids and the inhibitory potency of nonsteroidal anti-inflammatory substances, brought these drugs (NSAIDs) into the field of interest [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24]. …”